GB202318596D0 - Compounds for use in treatment and prophylaxis - Google Patents

Compounds for use in treatment and prophylaxis

Info

Publication number
GB202318596D0
GB202318596D0 GBGB2318596.0A GB202318596A GB202318596D0 GB 202318596 D0 GB202318596 D0 GB 202318596D0 GB 202318596 A GB202318596 A GB 202318596A GB 202318596 D0 GB202318596 D0 GB 202318596D0
Authority
GB
United Kingdom
Prior art keywords
prophylaxis
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2318596.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Original Assignee
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow filed Critical University of Glasgow
Priority to GBGB2318596.0A priority Critical patent/GB202318596D0/en
Publication of GB202318596D0 publication Critical patent/GB202318596D0/en
Pending legal-status Critical Current

Links

GBGB2318596.0A 2023-12-05 2023-12-05 Compounds for use in treatment and prophylaxis Pending GB202318596D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2318596.0A GB202318596D0 (en) 2023-12-05 2023-12-05 Compounds for use in treatment and prophylaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2318596.0A GB202318596D0 (en) 2023-12-05 2023-12-05 Compounds for use in treatment and prophylaxis

Publications (1)

Publication Number Publication Date
GB202318596D0 true GB202318596D0 (en) 2024-01-17

Family

ID=89507976

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2318596.0A Pending GB202318596D0 (en) 2023-12-05 2023-12-05 Compounds for use in treatment and prophylaxis

Country Status (1)

Country Link
GB (1) GB202318596D0 (en)

Similar Documents

Publication Publication Date Title
EP4043075C0 (en) Kn-93 for use in preventing and treating psoriasis
EP4136254A4 (en) Ace2-targeted compositions and methods for treating covid-19
IL277315B (en) Methods and composition for treating coronavirus infection
ZA202207493B (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
EP4149464A4 (en) Thiol-containing compounds for use in treating coronavirus
GB202318596D0 (en) Compounds for use in treatment and prophylaxis
GB202019762D0 (en) Compounds for use in treatment and prophylaxis
GB201918414D0 (en) Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
GB201918413D0 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB202217355D0 (en) Methods for the prophylaxis and treatment of Covid and Covid-19
GB201918539D0 (en) Compounds for use in treatment and prophylaxis
PL3860582T3 (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
GB202014736D0 (en) Novel compounds and their use in therapy
IL272078A (en) Cannabinoids for use in treatment
PL3797771T3 (en) Rebamipide for use in prophylaxis and treatment of celiac disease
GB202002299D0 (en) Agents for use in the treatment of tissue damage
IL310580A (en) Raloxifene for use in the treatment of sars-cov-2 variants infections
GB202108544D0 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB202108543D0 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB202108542D0 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB2610895B (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202302121D0 (en) Compounds for use in the treatment of schizophrenia
IL306046A (en) A composition for use in treating mhc-1-opathies
GB202003059D0 (en) Compounds for use in a method of treating, preventing and/or reducing the symptoms of pain
AU2023902805A0 (en) Combination for use in the treatment of glioma